Forbes July 31, 2024
William A. Haseltine

A recent Harvard study introduces a new method for treating spinal muscular atrophy. The study used “base editing” to target the disease’s root cause by modifying the survival motor neuron gene. For many years, a rare condition called spinal muscular atrophy (SMA) has brought heartbreak to families around the world. This genetic disorder affects a baby’s ability to move, breathe, and grow normally. It has been the leading genetic cause of infant mortality, forcing parents to witness their young children battling this problematic condition, facing an unimaginable struggle.

Spinal muscular atrophy affects the nerves that control muscle movement, leading to progressive weakening. As a result, infants with this condition often struggle with basic activities like lifting their heads, rolling over,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article